Jump to content
Comments are closed. Still search and read. Click this red line for lots of support - phone numbers for prostate cancer nurses, psychologist, an advanced man, local groups, depression support, several online and Facebook groups, videos. (JimJimJimJim.com)

AR - V7 - Resistance to Enzalutamide and Aberiterone

Charles (Chuck) Maack

By Charles (Chuck) Maack
in Secondary hormone therapy

Recommended Posts

Charles (Chuck) Maack Newbie

Charles (Chuck) Maack

Posted
Posted

AR-V7 is an androgen receptor variant which, if found in the blood stream, disables the effectiveness of either Xtandi/enzalutamide or Zytiga/abiraterone acetate.

 

I have prepared a summary of recent research about AR-V7 which is available at http://tinyurl.com/qbgpezo

 

[Ed - Chuck's paper mentions blood tests for Circulating Tumour Cells (CTC) and AR-V7.  These tests are not routinely available in Australia.]

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing
×
×
  • Create New...